Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)

OBJECTIVE: Retrospective data analyses have suggested that carbonic anhydrase IX (CAIX) may have a predictive role in patients with metastatic clear cell renal cell carcinoma (ccRCC) receiving high dose interleukin-2 or sorafenib. We examined the predictive value of CAIX in estimating treatment outc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Urol Oncol
Main Authors: Choueiri, Toni K., Cheng, Suchun, Qu, Angela Q., Pastorek, Jaromir, Atkins, Michael B., Signoretti, Sabina
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522691/
https://ncbi.nlm.nih.gov/pubmed/23141780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2012.07.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki